Search - tctmd.com

Displaying 281 - 289 of 289

Presentation TCT 2012

Clinical impact of renal function recovery after contrast induced nephropathy on long-term adverse event.

Presenter: Hyuck Jun Yoon, Ji Hyun Sohn, Ho Myung Lee, Hyun ok Cho, Hong Won Shin, Yun-Kyeong Cho, Hyoung-Seob Park, Hyungseop Kim, Chang-Wook Nam, Seung Ho Hur, Yoon-Nyun Kim, Kwon Bae Kim

January 03, 2012

News Conference News

RAPID GENE: Validation of Point-of-Care Genetic Testing

November 09, 2011

News Conference News

ADAPT-DES: Risk of Early Stent Thrombosis in DES Predicted by Platelet Inhibition

November 09, 2011

News Conference News

Ongoing Trials Explore Potential Benefits of Transradial PCI

November 08, 2011

News Conference News

Registry Studies Focus on Different TAVR Access Routes

November 07, 2011

News Conference News

Early Discontinuation of DAPT May Increase Risk of Stent Thrombosis

November 06, 2011

Video

» Interview

A Randomised Controlled Trial Assessing The Value CTCA In Improving Patient Satisfaction And Reducing Contrast Load, Procedural Duration And Complications In Patients Who Had Previous CABG Undergoing Invasive Coronary Angiography

September 18, 2022

Video

REMEDIAL III: A Randomized Trial of Urine Flow Rate-Guided vs. LVEDP-Guided Hydration in Patients at High Risk for Contrast Nephropathy

September 29, 2019

Video

» Interview

Dr. C. Michael Gibson Talks With Dr. Carlo Brigouri About REMEDIAL III: A Randomized Trial of Urine Flow Rate-Guided vs LVEDP-Guided Hydration in Patients at High Risk for Contrast Nephropathy

September 26, 2019

Advertisement

Clinical impact of renal function recovery after contrast induced nephropathy on long-term adverse event.

RAPID GENE: Validation of Point-of-Care Genetic Testing

ADAPT-DES: Risk of Early Stent Thrombosis in DES Predicted by Platelet Inhibition

Ongoing Trials Explore Potential Benefits of Transradial PCI

Registry Studies Focus on Different TAVR Access Routes

Early Discontinuation of DAPT May Increase Risk of Stent Thrombosis

A Randomised Controlled Trial Assessing The Value CTCA In Improving Patient Satisfaction And Reducing Contrast Load, Procedural Duration And Complications In Patients Who Had Previous CABG Undergoing Invasive Coronary Angiography

REMEDIAL III: A Randomized Trial of Urine Flow Rate-Guided vs. LVEDP-Guided Hydration in Patients at High Risk for Contrast Nephropathy

Dr. C. Michael Gibson Talks With Dr. Carlo Brigouri About REMEDIAL III: A Randomized Trial of Urine Flow Rate-Guided vs LVEDP-Guided Hydration in Patients at High Risk for Contrast Nephropathy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content